AI continues to capture the headlines. One recent headline noted that ChatGPT passed the medical boards. In this third episode, Stephen Piepgrass and colleagues Michael Yaghi and Barry Boise discuss the potential risks health care companies may face with increased reliance on AI, as well as the increased focus on AI by various regulators and state attorneys general, particularly in the health care space.

Our panel also offers suggestions on how health care companies can engage with state regulators to discuss the issues, share their perspective on how AI could assist the health care industry, and create an ongoing dialogue with regulators to make sure that private industry and the government are working together.

In part four of this podcast series, we will look at the use and impact of AI in the financial services industry.

Transcript: AI: Impact and Use in the Health Care Industry (Part Three) (PDF)

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Stephen C. Piepgrass Stephen C. Piepgrass

Stephen leads the firm’s Regulatory Investigations, Strategy + Enforcement (RISE) Practice Group. He focuses his practice on enforcement actions, investigations, and litigation. Stephen primarily represents clients engaging with, or being investigated by, state attorneys general and other state or local governmental enforcement bodies,

Stephen leads the firm’s Regulatory Investigations, Strategy + Enforcement (RISE) Practice Group. He focuses his practice on enforcement actions, investigations, and litigation. Stephen primarily represents clients engaging with, or being investigated by, state attorneys general and other state or local governmental enforcement bodies, including the CFPB and FTC, as well as clients involved with litigation, with a particular focus on heavily regulated industries. He also has experience advising clients on data and privacy issues, including handling complex investigations into data incidents by state attorneys general other state and federal regulators. Additionally, Stephen provides strategic counsel to Troutman Pepper’s Strategies clients who need assistance with public policy, advocacy, and government relations strategies.

Photo of Michael Yaghi Michael Yaghi

Michael is a partner in the firm’s State Attorneys General and Regulatory Investigations, Strategy + Enforcement (RISE) Practice Groups, nationwide teams that advise clients on consumer protection enforcement matters and other regulatory issues. Based in the firm’s Orange County office, Michael represents high-profile…

Michael is a partner in the firm’s State Attorneys General and Regulatory Investigations, Strategy + Enforcement (RISE) Practice Groups, nationwide teams that advise clients on consumer protection enforcement matters and other regulatory issues. Based in the firm’s Orange County office, Michael represents high-profile clients in regulatory enforcement investigations involving all facets of their business, including but not limited to, advertising and sales practices, monthly membership programs, auto renewal programs, telemarketing and telephone solicitations, door-to-door sales practices, and endorsements. Having begun his career as a commercial litigator, he also supports clients throughout litigation, should an investigation move in that direction.

Photo of Barry Boise Barry Boise

Barry’s primary emphasis is the counseling and defense of pharmaceutical and medical device companies from early stage through marketed products. He has substantial experience litigating multidistrict litigation and coordinated state court litigation. Barry represents life science, health care, and technology companies in attorney…

Barry’s primary emphasis is the counseling and defense of pharmaceutical and medical device companies from early stage through marketed products. He has substantial experience litigating multidistrict litigation and coordinated state court litigation. Barry represents life science, health care, and technology companies in attorney general investigations and litigation, and in other civil and criminal actions involving health care fraud and abuse.